help button home button Am J Pathol ASIP WHAT IS IT?
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Order Full text via Infotrieve
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lubensky, I. A.
Right arrow Articles by Zhuang, Z.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lubensky, I. A.
Right arrow Articles by Zhuang, Z.

American Journal of Pathology, Vol 149, 2089-2094, Copyright © 1996 by American Society for Investigative Pathology

REGULAR ARTICLES

Allelic deletions of the VHL gene detected in multiple microscopic clear cell renal lesions in von Hippel-Lindau disease patients

IA Lubensky, JR Gnarra, P Bertheau, MM Walther, WM Linehan and Z Zhuang
Laboratory of Pathology, National Cancer Institute, Bethesda, Maryland 20892, USA.

Patients with von Hippel-Lindau (VHL) disease develop a spectrum of bilateral clear-cell renal lesions including cysts and renal cell carcinomas (RCCs). VHL gene deletions have been previously reported in VHL-associated macroscopic RCC. Although histological analysis suggests that microscopic cystic lesions in the VHL patients may represent precursors of the RCC, there is at present no direct molecular evidence of their relationship. To investigate the relationship between cystic lesions and RCC, 26 microdissected archival renal lesions from two VHL disease patients were studied for loss of heterozygosity at the VHL gene locus using polymerase chain reaction single-strand conformation polymorphism analysis. The renal lesions included 2 benign cysts, 5 atypical cysts, 5 microscopic RCCs in situ, 5 cysts lined by a single layer of cells, in which RCCs in situ were developing, and 2 microscopic and 7 macroscopic RCCs. Except for a single benign cyst, 25 of 26 renal lesions showed nonrandom allelic loss of the VHL gene. In either of the 2 patients, the same VHL allele was deleted in all of the lesions tested, indicating loss of the wild-type allele and retention of the inherited, mutated VHL allele. The results suggest that all clear-cell lesions in the VHL kidney represent neoplasms and that the loss of the VHL gene occurs early in their development. Atypical and benign cysts most likely represent the initial phenotype in malignant transformation to the RCC.


This article has been cited by other articles:


Home page
 Clin. Cancer Res.Home page
G. Bratslavsky, S. Sudarshan, L. Neckers, and W. M. Linehan
Pseudohypoxic Pathways in Renal Cell Carcinoma
Clin. Cancer Res., August 15, 2007; 13(16): 4667 - 4671.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
E. W. Kuehn, G. Walz, and T. Benzing
von Hippel-Lindau: A Tumor Suppressor Links Microtubules to Ciliogenesis and Cancer Development
Cancer Res., May 15, 2007; 67(10): 4537 - 4540.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
W. G. Kaelin Jr.
The von Hippel-Lindau Tumor Suppressor Protein and Clear Cell Renal Carcinoma
Clin. Cancer Res., January 15, 2007; 13(2): 680s - 684s.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
O. Iliopoulos
Molecular Biology of Renal Cell Cancer and the Identification of Therapeutic Targets
J. Clin. Oncol., December 10, 2006; 24(35): 5593 - 5600.
[Abstract] [Full Text] [PDF]

Home page
 J. Cell Biol.Home page
B. Schermer, C. Ghenoiu, M. Bartram, R. U. Muller, F. Kotsis, M. Hohne, W. Kuhn, M. Rapka, R. Nitschke, H. Zentgraf, et al.
The von Hippel-Lindau tumor suppressor protein controls ciliogenesis by orienting microtubule growth
J. Cell Biol., November 20, 2006; 175(4): 547 - 554.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
M. S. Lutz and R. D. Burk
Primary cilium formation requires von hippel-lindau gene function in renal-derived cells.
Cancer Res., July 15, 2006; 66(14): 6903 - 6907.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
C. Sourbier, V. Lindner, H. Lang, A. Agouni, E. Schordan, S. Danilin, S. Rothhut, D. Jacqmin, J.-J. Helwig, and T. Massfelder
The Phosphoinositide 3-Kinase/Akt Pathway: A New Target in Human Renal Cell Carcinoma Therapy.
Cancer Res., May 15, 2006; 66(10): 5130 - 5142.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
I. Talon, V. Lindner, C. Sourbier, E. Schordan, S. Rothhut, M. Barthelmebs, H. Lang, J.-J. Helwig, and T. Massfelder
Antitumor effect of parathyroid hormone-related protein neutralizing antibody in human renal cell carcinoma in vitro and in vivo
Carcinogenesis, January 1, 2006; 27(1): 73 - 83.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. Biol.Home page
J. An and M. B. Rettig
Mechanism of von Hippel-Lindau Protein-Mediated Suppression of Nuclear Factor kappa B Activity
Mol. Cell. Biol., September 1, 2005; 25(17): 7546 - 7556.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
M. I. Zhou, R. L. Foy, V. C. Chitalia, J. Zhao, M. V. Panchenko, H. Wang, and H. T. Cohen
Jade-1, a candidate renal tumor suppressor that promotes apoptosis
PNAS, August 2, 2005; 102(31): 11035 - 11040.
[Abstract] [Full Text] [PDF]

Home page
 Endocr. Rev.Home page
S. J. Marx and W. F. Simonds
Hereditary Hormone Excess: Genes, Molecular Pathways, and Syndromes
Endocr. Rev., August 1, 2005; 26(5): 615 - 661.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
T. W. A. Vogel, F. M. Brouwers, I. A. Lubensky, A. O. Vortmeyer, R. J. Weil, M. M. Walther, E. H. Oldfield, W. M. Linehan, K. Pacak, and Z. Zhuang
Differential Expression of Erythropoietin and Its Receptor in von Hippel-Lindau-Associated and Multiple Endocrine Neoplasia Type 2-Associated Pheochromocytomas
J. Clin. Endocrinol. Metab., June 1, 2005; 90(6): 3747 - 3751.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
Y.-S. Lee, A. O. Vortmeyer, I. A. Lubensky, T. W.A. Vogel, B. Ikejiri, S. Ferlicot, G. Benoit, S. Giraud, E. H. Oldfield, W. M. Linehan, et al.
Coexpression of Erythropoietin and Erythropoietin Receptor in Von Hippel-Lindau Disease-Associated Renal Cysts and Renal Cell Carcinoma
Clin. Cancer Res., February 1, 2005; 11(3): 1059 - 1064.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
W. Y. Kim and W. G. Kaelin
Role of VHL Gene Mutation in Human Cancer
J. Clin. Oncol., December 15, 2004; 22(24): 4991 - 5004.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
W. M. Linehan, J. Vasselli, R. Srinivasan, M. M. Walther, M. Merino, P. Choyke, C. Vocke, L. Schmidt, J. S. Isaacs, G. Glenn, et al.
Genetic Basis of Cancer of the Kidney: Disease-Specific Approaches to Therapy
Clin. Cancer Res., September 15, 2004; 10(18): 6282S - 6289S.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
W. G. Kaelin Jr.
The Von Hippel-Lindau Tumor Suppressor Gene and Kidney Cancer
Clin. Cancer Res., September 15, 2004; 10(18): 6290S - 6295S.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
M.-H. Tan, C. G. Rogers, J. T. Cooper, J. A. Ditlev, T. J. Maatman, X. Yang, K. A. Furge, and B. T. Teh
Gene Expression Profiling of Renal Cell Carcinoma
Clin. Cancer Res., September 15, 2004; 10(18): 6315S - 6321S.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Renal Physiol.Home page
R. I. Sufan, M. A. S. Jewett, and M. Ohh
The role of von Hippel-Lindau tumor suppressor protein and hypoxia in renal clear cell carcinoma
Am J Physiol Renal Physiol, July 1, 2004; 287(1): F1 - F6.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
A. O. Vortmeyer, S. Huang, I. Lubensky, and Z. Zhuang
Non-Islet Origin of Pancreatic Islet Cell Tumors
J. Clin. Endocrinol. Metab., April 1, 2004; 89(4): 1934 - 1938.
[Abstract] [Full Text] [PDF]

Home page
 INT J SURG PATHOLHome page
N. Kuroda, H. Satake, E. Miyazaki, Y. Hayashi, M. Hiroi, and H. Enzan
Collecting Duct Carcinoma Exhibiting Diastase-Resistant PAS-Positive Globular Cytoplasmic Inclusions and Rhabdoid Features Arising in Adult Polycystic Kidney Disease: A Case Report
International Journal of Surgical Pathology, April 1, 2004; 12(2): 171 - 177.
[Abstract] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
W. G. Kaelin Jr.
The von Hippel-Lindau Gene, Kidney Cancer, and Oxygen Sensing
J. Am. Soc. Nephrol., November 1, 2003; 14(11): 2703 - 2711.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
W. Ma, L. Tessarollo, S.-B. Hong, M. Baba, E. Southon, T. C. Back, S. Spence, C. G. Lobe, N. Sharma, G. W. Maher, et al.
Hepatic Vascular Tumors, Angiectasis in Multiple Organs, and Impaired Spermatogenesis in Mice with Conditional Inactivation of the VHL Gene
Cancer Res., September 1, 2003; 63(17): 5320 - 5328.
[Abstract] [Full Text] [PDF]

Home page
 JNCI J Natl Cancer InstHome page
J. Bryant, J. Farmer, L. J. Kessler, R. R. Townsend, and K. L. Nathanson
Pheochromocytoma: The Expanding Genetic Differential Diagnosis
J Natl Cancer Inst, August 20, 2003; 95(16): 1196 - 1204.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
C. A. Koch, K. Pacak, and G. P. Chrousos
The Molecular Pathogenesis of Hereditary and Sporadic Adrenocortical and Adrenomedullary Tumors
J. Clin. Endocrinol. Metab., December 1, 2002; 87(12): 5367 - 5384.
[Abstract] [Full Text] [PDF]

Home page
 INT J SURG PATHOLHome page
C. N. Otis, P. A. Krebs, A. Albuquerque, M. M. Quezado, X. S. Juan, M. E. Sobel, and M. J. Merino
Loss of Heterozygosity of p53, BRCA1, VHL, and Estrogen Receptor Genes in Breast Carcinoma: Correlation with Related Protein Products and Morphologic Features
International Journal of Surgical Pathology, October 1, 2002; 10(4): 237 - 245.
[Abstract] [PDF]

Home page
 Cell Growth Differ.Home page
H. Yang and W. G. Kaelin Jr.
Molecular Pathogenesis of the Von Hippel-Lindau Hereditary Cancer Syndrome: Implications for Oxygen Sensing
Cell Growth Differ., September 1, 2001; 12(9): 447 - 455.
[Full Text] [PDF]

Home page
 Physiol. GenomicsHome page
S. A. KARUMANCHI, L. JIANG, B. KNEBELMANN, A. K. STUART-TILLEY, S. L. ALPER, and V. P. SUKHATME
VHL tumor suppressor regulates Cl-/HCO3- exchange and Na+/H+ exchange activities in renal carcinoma cells
Physiol Genomics, April 2, 2001; 5(3): 119 - 128.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
V. H. Mohr, A. O. Vortmeyer, Z. Zhuang, S. K. Libutti, M. M. Walther, P. L. Choyke, B. Zbar, W. M. Linehan, and I. A. Lubensky
Histopathology and Molecular Genetics of Multiple Cysts and Microcystic (Serous) Adenomas of the Pancreas in von Hippel-Lindau Patients
Am. J. Pathol., November 1, 2000; 157(5): 1615 - 1621.
[Abstract] [Full Text] [PDF]

Home page
 JNCI J Natl Cancer InstHome page
M. Los, O. A. J. Kerckhaert, R. Zewald, H. K. P. van Amstel, and E. E. Voest
Mutational Analysis of Endothelial Cells Derived From von Hippel-Lindau-Related Renal Cancer
J Natl Cancer Inst, October 18, 2000; 92(20): 1688 - 1689.
[Full Text] [PDF]

Home page
 Cancer Res.Home page
A. Schneider, S. Borgnat, H. Lang, O. Régine, V. Lindner, M. Kassem, C. Saussine, P. Oudet, D. Jacqmin, and M. P. Gaub
Evaluation of Microsatellite Analysis in Urine Sediment for Diagnosis of Bladder Cancer
Cancer Res., August 1, 2000; 60(16): 4617 - 4622.
[Abstract] [Full Text]

Home page
 Proc. Natl. Acad. Sci. USAHome page
A. R. Schoenfeld, E. J. Davidowitz, and R. D. Burk
Elongin BC complex prevents degradation of von Hippel-Lindau tumor suppressor gene products
PNAS, July 18, 2000; 97(15): 8507 - 8512.
[Abstract] [Full Text] [PDF]

Home page
 INT J SURG PATHOLHome page
T. Shen, Z. Zhuang, D. J. Gersell, and F. A. Tavassoli
Allelic Deletion of VHL Gene Detected in Papillary Tumors of the Broad Ligament, Epididymis, and Retroperitoneum in von Hippel-Lindau Disease Patients
International Journal of Surgical Pathology, July 1, 2000; 8(3): 207 - 212.
[Abstract] [PDF]

Home page
 Am. J. Pathol.Home page
I. A. Lubensky, L. Schmidt, Z. Zhuang, G. Weirich, S. Pack, N. Zambrano, M. M. Walther, P. Choyke, W. M. Linehan, and B. Zbar
Hereditary and Sporadic Papillary Renal Carcinomas with c-met Mutations Share a Distinct Morphological Phenotype
Am. J. Pathol., August 1, 1999; 155(2): 517 - 526.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
S. Ananth, B. Knebelmann, W. Gruning, M. Dhanabal, G. Walz, I. E. Stillman, and V. P. Sukhatme
Transforming Growth Factor {beta}1 Is a Target for the von Hippel-Lindau Tumor Suppressor and a Critical Growth Factor for Clear Cell Renal Carcinoma
Cancer Res., May 1, 1999; 59(9): 2210 - 2216.
[Abstract] [Full Text] [PDF]

Home page
 Arch OphthalmolHome page
C.-C. Chan, A. O. Vortmeyer, E. Y. Chew, W. R. Green, D. M. Matteson, D. F. Shen, W. M. Linehan, I. A. Lubensky, and Z. Zhuang
VHL Gene Deletion and Enhanced VEGF Gene Expression Detected in the Stromal Cells of Retinal Angioma
Arch Ophthalmol, May 1, 1999; 117(5): 625 - 630.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. Biol.Home page
S. Lee, M. Neumann, R. Stearman, R. Stauber, A. Pause, G. N. Pavlakis, and R. D. Klausner
Transcription-Dependent Nuclear-Cytoplasmic Trafficking Is Required for the Function of the von Hippel-Lindau Tumor Suppressor Protein
Mol. Cell. Biol., February 1, 1999; 19(2): 1486 - 1497.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
O. Iliopoulos, M. Ohh, and W. G. Kaelin Jr.
pVHL19 is a biologically active product of the von Hippel-Lindau gene arising from internal translation initiation
PNAS, September 29, 1998; 95(20): 11661 - 11666.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
I. A. Lubensky, S. Pack, D. Ault, A. O. Vortmeyer, S. K. Libutti, P. L. Choyke, M. M. Walther, W. M. Linehan, and Z. Zhuang
Multiple Neuroendocrine Tumors of the Pancreas in von Hippel-Lindau Disease Patients : Histopathological and Molecular Genetic Analysis
Am. J. Pathol., July 1, 1998; 153(1): 223 - 231.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. Biol.Home page
K. M. Lonergan, O. Iliopoulos, M. Ohh, T. Kamura, R. C. Conaway, J. W. Conaway, and W. G. Kaelin Jr.
Regulation of Hypoxia-Inducible mRNAs by the von Hippel-Lindau Tumor Suppressor Protein Requires Binding to Complexes Containing Elongins B/C and Cul2
Mol. Cell. Biol., February 1, 1998; 18(2): 732 - 741.
[Abstract] [Full Text]

Home page
 Proc. Natl. Acad. Sci. USAHome page
A. Pause, S. Lee, R. A. Worrell, D. Y. T. Chen, W. H. Burgess, W. M. Linehan, and R. D. Klausner
The von Hippel-Lindau tumor-suppressor gene product forms a stable complex with human CUL-2, a member of the Cdc53 family of proteins
PNAS, March 18, 1997; 94(6): 2156 - 2161.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1996 by the American Society for Investigative Pathology.